Mikov, Momir
Date issued
Fulltext
Results 1-4 of 4 (Search time: 0.002 seconds).
Issue Date | Title | Author(s) | |
---|---|---|---|
1 | 1-Jan-2015 | An advanced microencapsulated system: A platform for optimized oral delivery of antidiabetic drug-bile acid formulations | Mooranian A.; Negrulj R.; Mathavan S.; Martinez J.; Sciarretta J.; Chen-Tan N.; Mukkur T.; Momir Mikov ; Mladena Lalić-Popović ; Maja Stojančević; Svetlana Goločorbin-Kon ; Al-Salami H. |
2 | 1-Jan-2008 | The influence of 3α,7α-dihydroxy-12-keto-5β-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes | Momir Mikov ; Hani Al-Salami; Svetlana Goločorbin-Kon ; Ranko Škrbić; Aleksandar Rašković ; Paul J. Fawcett |
3 | 28-Jul-2014 | Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterization study | Mooranian A.; Negrulj R.; Chen-Tan N.; Al-Sallami H.; Fang Z.; Mukkur T.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Arfuso F.; Al-Salami H. |
4 | 2019 | Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Saša Vukmirović ; Jelena Lazić; Hani Al-Salami; Momir Mikov |